Depression and Anxiety Trial, Recruiting NCT06603064 Sponsor: University of Pittsburgh Condition: Depression and Anxiety
Back to Depression And Anxiety

Depression and Anxiety Trial, Recruiting

NCT06603064
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have not taken most types of prescription medications (such as heart medications, anti-seizure medications, antipsychotics, insulin, chemotherapy, or immunosuppressants) in the past 14 days
  • People who take certain medications (such as short-acting benzodiazepines, asthma inhalers, steroids, or medical marijuana) fewer than 7 out of the past 14 days may still be considered
  • People who take longer-acting benzodiazepines or sleep medications, as long as those medications were not taken within 48 hours of the brain scan
  • People who take no more than two non-insulin diabetes medications on a regular basis
  • People who stopped taking a disallowed medication at least one month ago and meet all other criteria

Who may not be able to join:

  • People who have had 35 or more alcoholic drinks in the past 7 days, or who have had 6 or more drinks on 3 or more separate occasions in the past 7 days
  • People who have used illegal drugs on 7 or more days in the past 2 weeks
  • People with epilepsy or a history of seizures
  • People with a history of heart attack, stroke, bypass surgery, angioplasty, heart failure, or irregular heart rhythm
  • People with very high blood pressure (above 160 systolic and/or above 100 diastolic)
  • People who have received cancer treatment in the past 12 months (except for non-melanoma skin cancer)
  • People with liver disease or kidney disease
  • People with Type 1 diabetes
  • People with a history of a major neurological condition or brain injury that still causes ongoing symptoms or thinking difficulties (such as multiple sclerosis, cerebral palsy, or a serious head injury)
  • People with a history of schizophrenia or bipolar disorder
  • People with a lung disease that requires ongoing drug treatment (though occasional use of asthma or allergy inhalers is not automatically disqualifying)
  • People who are pregnant or planning to become pregnant in the next 3 months
  • People with a visual impairment that would prevent them from reading printed or on-screen text
  • People with colour blindness that may affect their ability to distinguish colours on study tasks
  • People who are not comfortable in confined spaces and would not be comfortable in an MRI scanner (a mock MRI trial run may be offered to help people decide)
  • People who have non-removable metal implants, devices, or objects in or on the body that are not compatible with MRI (compatibility of medical devices may be assessed with documentation from a medical professional)
  • People who are taller than 7 feet 2 inches or weigh more than 350 pounds, as they may not fit in the MRI scanner
  • People who frequently work night shifts (where half or more of a full workday falls between midnight and 8am, occurring more than 12 times in the past year)
  • People who have undergone brain stimulation procedures (such as TMS, tDCS, vagus nerve stimulation, or transcranial ultrasound) as part of research or treatment in the past month
  • People with a lifetime history of a suicide attempt, or who have experienced suicidal thoughts within the past year

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 6 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Thomas E Kraynak, PhD, University of Pittsburgh

Phone: 412-246-6361

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
9 April 2025
Est. completion
1 July 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Dorsal anterior cingulate cortex activation to stress; Dorsal anterior cingulate cortex connectivity to stress; Change in arousal during stress; Change in valence during stress; Change in perceived control during stress; Systolic blood pressure response to stress; Heart rate response to stress

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 6 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov